Mackenzie Financial Corp Sells 182,908 Shares of Marsh & McLennan Companies, Inc. $MRSH

Mackenzie Financial Corp decreased its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 8.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,102,286 shares of the financial services provider’s stock after selling 182,908 shares during the period. Mackenzie Financial Corp owned about 0.43% of Marsh & McLennan Companies worth $423,674,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Brighton Jones LLC increased its stake in shares of Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC increased its position in Marsh & McLennan Companies by 39.6% in the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock valued at $651,000 after acquiring an additional 869 shares in the last quarter. Wedbush Securities Inc. raised its stake in shares of Marsh & McLennan Companies by 60.8% in the second quarter. Wedbush Securities Inc. now owns 1,661 shares of the financial services provider’s stock worth $363,000 after acquiring an additional 628 shares during the last quarter. AE Wealth Management LLC grew its stake in shares of Marsh & McLennan Companies by 12.7% during the second quarter. AE Wealth Management LLC now owns 3,959 shares of the financial services provider’s stock valued at $866,000 after purchasing an additional 446 shares during the last quarter. Finally, Prospera Financial Services Inc raised its position in Marsh & McLennan Companies by 181.6% in the 2nd quarter. Prospera Financial Services Inc now owns 8,166 shares of the financial services provider’s stock worth $1,786,000 after purchasing an additional 5,266 shares during the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on MRSH. Wells Fargo & Company increased their price objective on Marsh & McLennan Companies from $199.00 to $203.00 and gave the company an “equal weight” rating in a research report on Friday, January 30th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $200.00 price target on shares of Marsh & McLennan Companies in a research note on Friday, January 30th. Barclays lifted their price objective on Marsh & McLennan Companies from $206.00 to $210.00 and gave the stock an “overweight” rating in a research report on Thursday, January 8th. Cantor Fitzgerald upped their target price on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Finally, Evercore lowered their price target on shares of Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating for the company in a research report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $216.18.

Insider Transactions at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.35% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of MRSH stock opened at $173.93 on Wednesday. Marsh & McLennan Companies, Inc. has a 12 month low of $170.37 and a 12 month high of $248.00. The firm has a market capitalization of $84.20 billion, a PE ratio of 20.63, a price-to-earnings-growth ratio of 2.45 and a beta of 0.74. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.10 and a current ratio of 1.10.

Marsh & McLennan Companies (NYSE:MRSH) last released its earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.97 by $0.15. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The business had revenue of $6.60 billion during the quarter, compared to the consensus estimate of $6.52 billion. During the same quarter last year, the firm earned $1.87 earnings per share. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a $0.90 dividend. The ex-dividend date of this dividend is Thursday, April 9th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 2.1%. Marsh & McLennan Companies’s payout ratio is currently 42.70%.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.